A model informed approach to assess the risk of checkpoint inhibitors induced myocarditis

Immune checkpoint inhibitors (ICIs), as a novel immunotherapy, are designed to modulate the immune system to attack malignancies. Despite their promising benefits, immune-related adverse events (IRAEs) may occur, and incidences are bound to increase with surging demand of this class of drugs in trea...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: ven der Vegt, S, Wang, Y, Polonchuk, L, Wang, K, Waters, S, Baker, RE
Formaat: Journal article
Taal:English
Gepubliceerd in: Frontiers Media 2022

Gelijkaardige items